Nasri in Spanish doping probe after vitamin booster

2016-12-28 20:32
Samir Nasri (Getty Images)

Madrid - French midfielder Samir Nasri, on loan to La Liga club Sevilla from Manchester City, is under investigation by the Spanish Anti-Doping Agency after being named by a Los Angeles clinic as a recipient of a intravenous vitamin treatment.

"Following the publication of this information, the agency launched an investigation to find out what the treatment is," a source from the AEPSAD agency told AFP on condition of anonymity.

"The presence of a sportsman in a clinic like this is suspicious as such."

The probe was initiated after the Los Angeles-based Drip Doctors clinic tweeted that it had treated Nasri, saying its Immunity Drip IV would allow the French player to stay hydrated and on top form throughout the tough season.

Drip Doctors say they specialise in not only intravenous vitamin therapy and hydration, but also anti-aging and cosmetic enhancements.

The drip treatement Nasri allegedly received includes vitamins C and B, amino acid lysine and zinc, all combined with "specially formulated nutrients to help combat superbugs and common viruses".

The report went viral after Nasri's twitter account was hacked.

The Spanish Anti-Doping Agency was in contact with "all parties", the source said.

Read more on:    samir nasri  |  soccer


Read News24’s Comments Policy

Love 2 Meet
Sport24 on Twitter

Follow Sport24 news on Twitter


The 2018/19 Absa Premiership season is in full swing. Will Mamelodi Sundowns retain their title? Or can one of Kaizer Chiefs, Orlando Pirates, Wits, SuperSport United - or another team perhaps - snatch glory from the Brazilians? Be sure to visit Sport24 for all the latest news!

Latest blogs

After Stuart Baxter stepped down as Bafana Bafana head coach, who would you like to see take over?

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

There are new stories on the homepage. Click here to see them.